Fact-checked by Grok 2 weeks ago

Gary Taubes

Gary Taubes (born April 30, 1956) is an American investigative science and health journalist renowned for scrutinizing the evidence behind mainstream nutritional advice. His work emphasizes the causal role of carbohydrates and insulin in driving , , and related chronic diseases, challenging the calorie-balance model and low-fat dietary paradigms that have dominated policy since the late . Taubes holds a in from (1977), a master's in from (1978), and a master's in from (1981). Beginning his career as a reporter for Discover magazine in 1982 and later as a contributing correspondent for Science, Taubes earned accolades including the Science in Society Journalism Award for his exposés on scientific controversies, such as cold fusion and particle physics. In books like Good Calories, Bad Calories (2007), Why We Get Fat and What to Do About It (2010), The Case Against Sugar (2016), and Rethinking Diabetes (2024), he marshals historical data, clinical trials, and physiological reasoning to argue that refined carbohydrates and sugars, rather than dietary fat or mere caloric excess, are primary drivers of metabolic dysfunction. These publications have influenced the resurgence of low-carbohydrate diets and prompted reevaluations of federal dietary guidelines. Taubes co-founded the Nutrition Science Initiative (NuSI) in 2012 to fund controlled experiments testing insulin-centric hypotheses of , independent of industry influence. Despite yielding insights into energy expenditure and fat storage, NuSI dissolved in 2021 amid challenges in replicating expected results under feeding conditions, highlighting persistent methodological issues in research. His critiques have sparked , with proponents crediting empirical rigor and detractors questioning interpretations of hormonal mechanisms over caloric , though Taubes maintains that institutional biases in and have sidelined dissenting evidence.

Early Life and Education

Academic Background and Influences

Taubes earned a (S.B.) degree in from in 1977. His undergraduate studies focused on physics, with a particular interest in , reflecting an early attraction to fundamental questions in the natural sciences. Following Harvard, he pursued graduate work at , obtaining a (M.S.) in in 1978, specializing in or aeronautical engineering. Subsequently, Taubes shifted toward professional communication of science, completing a in journalism at in 1981. This transition stemmed from disillusionment with pure research paths in physics and during the late , when job prospects in those fields appeared limited amid economic conditions and personal reassessment. His physics training instilled a methodological rigor—emphasizing mechanistic explanations, controlled experimentation, and skepticism toward unverified hypotheses—that later informed his journalistic scrutiny of scientific claims, particularly in fields reliant on correlational data like . No specific academic mentors are prominently cited in Taubes' biographical accounts, though his foundational exposure to physics' first-principles approach contrasted sharply with the observational paradigms he later critiqued in nutrition science. This fostered an enduring emphasis on over association in evaluating , a perspective evident in his career-long advocacy for re-examining consensus views through primary sources and historical context.

Journalistic Career

Initial Reporting in Physics and Controversial Science

Taubes entered science journalism after earning a in journalism from in 1981, following undergraduate studies in at and graduate work in at . His initial reporting focused on high-energy , drawing on his technical background to cover the competitive dynamics at major research facilities. In the mid-1980s, he spent ten months embedded at , the European particle physics laboratory near , observing the intense rivalries among scientists pursuing discoveries that could yield Nobel Prizes. This immersion informed his first book, Nobel Dreams: Power, Deceit, and the Ultimate Experiment, published in 1986, which chronicled the high-stakes quest to detect the W and Z bosons—subatomic particles confirming the electroweak theory of unified forces. Taubes detailed the interpersonal conflicts, resource battles, and methodological pressures within Carlo Rubbia's UA1 collaboration, which ultimately shared the 1984 for the boson discoveries, though the book emphasized the precarity and human elements often obscured in official narratives. The work highlighted how institutional politics and experimental uncertainties could undermine even foundational physics advancements, establishing Taubes' approach of scrutinizing not just results but the processes yielding them. Taubes' coverage extended to emerging controversies in physics, exemplified by his skeptical reporting on following the March 23, 1989, announcement by chemists Martin Fleischmann and at the claiming room-temperature in electrolytic cells. As a freelance contributor to magazine, he published articles such as "The Cold Fusion Conundrum" on June 15, 1990, documenting failed replications, anomalous tritium detections suggestive of contamination or fraud, and institutional reluctance to retract premature claims despite mounting evidence of irreproducibility. His investigations revealed procedural flaws, including uncalibrated calorimeters and selective data reporting, which invalidated the excess heat measurements purportedly indicating fusion. These efforts culminated in Bad Science: The Short Life and Weird Times of Cold Fusion (1993), a 503-page exposé portraying the episode as a case of "pathological science"—hypotheses persisting despite contradictory evidence due to experimenter bias and media amplification. Taubes argued that the rush to extraordinary claims without rigorous controls exemplified broader vulnerabilities in scientific practice, particularly when non-experts in nuclear physics entered the field, leading to widespread replication failures by mid-1989 and eventual dismissal by mainstream physicists. Through archival records, interviews with over 100 researchers, and analysis of experimental logs, he demonstrated how initial enthusiasm from university administrations and press coverage ignored basic verification standards, resulting in professional repercussions for proponents like Pons and Fleischmann, who faced scrutiny for data inconsistencies. This phase of Taubes' reporting underscored his method of privileging empirical reproducibility over theoretical allure, influencing his later critiques in other scientific domains.

Transition to Health and Nutrition Journalism

Taubes shifted his investigative focus to health-related topics in the late 1990s, applying the same rigorous scrutiny he had employed in physics and other contentious scientific domains. His entry point was an examination of the salt-hypertension hypothesis, culminating in the 1998 Science article "The (Political) Science of Salt," which dissected three decades of research and revealed inconsistencies in the evidence supporting population-wide salt reduction recommendations. This piece, awarded the 1998 Science in Society Journalism Award by the National Association of Science Writers, underscored how institutional pressures and selective interpretation of data mirrored flaws Taubes had previously documented in fields like cold fusion. Building on this, Taubes next targeted the dietary fat paradigm, publishing "The Soft Science of Dietary Fat" in on March 30, 2001. In this analysis, he reviewed the historical development of anti-fat guidelines, interviewing approximately 140 researchers, policymakers, and clinicians, and concluded that despite billions spent on studies since the , the causal link between intake and heart disease lacked definitive empirical support, relying instead on associative prone to variables. The article exposed how U.S. government reports, such as the 1988 Surgeon General's on , amplified tentative hypotheses into policy without resolving underlying mechanistic uncertainties. These investigations marked Taubes' pivot to as a core beat, as they revealed systemic parallels to the "pathological" science-media dynamics he critiqued earlier. His 2002 New York Times Magazine cover story, "What If It's All Been a Big Fat Lie?", extended this critique by challenging the post-World War II consensus on low-fat , positing refined carbohydrates—rather than total calories or fats—as drivers of epidemics through hormonal dysregulation. The piece, which interviewed pioneers like low-carbohydrate advocate Robert Atkins, ignited widespread debate and positioned Taubes as a leading skeptic of mainstream nutritional , where observational data often supplanted controlled trials amid potential biases from funding and ideology. This transition reflected Taubes' method of privileging causal evidence over correlative claims, leading to his subsequent book-length explorations of and metabolic disease.

Challenges to Mainstream Nutrition Paradigms

Critique of Dietary Fat Hypothesis

Gary Taubes has argued that the dietary fat hypothesis, which posits that saturated fats elevate levels and thereby cause heart disease, rests on flawed observational data and lacks support from randomized controlled trials. In his 2001 article in Science, Taubes detailed how early proponents like selectively used data from the Seven Countries Study, correlating fat intake with heart disease in seven nations while ignoring 15 others where no such association existed, thus establishing a spurious causal link without experimental validation. This hypothesis gained traction post-World War II amid rising heart disease diagnoses, which Taubes attributes partly to improved diagnostics rather than dietary shifts, as fat consumption remained stable while refined carbohydrate intake surged. Taubes critiques the leap from association to policy, noting that the American Heart Association's 1961 endorsement of low-fat diets for all Americans preceded robust evidence, influenced by Keys' advocacy despite dissenting researchers like Yerushalmy and Stamler who highlighted confounders such as and . He points out that large cohort studies, including the tracking over 80,000 women from 1980 to 1994, found no association between total or intake and coronary heart disease risk, with monounsaturated fats appearing protective and saturated fats at most marginally harmful after adjusting for confounders. Similarly, the Framingham Heart Study's long-term data linked to disease but failed to demonstrate that dietary fat reduction lowered risk independently. Experimental trials underscore Taubes' contention that replacing saturated fats with polyunsaturated vegetable oils does not reduce—and may increase—mortality. The Sydney Diet Heart Study (1966–1973), involving 458 men post-heart attack, randomized participants to a diet high in from oil versus a control; reanalysis in 2013 revealed a 62% higher all-cause mortality and 74% higher cardiovascular mortality in the intervention group, despite reduction. The Minnesota Coronary Experiment (1968–1973), the largest such trial with over 9,000 participants in mental institutions and nursing homes, substituted and for saturated fats, lowering serum by 13.8% yet yielding a 22% increase in mortality per 30 mg/dL drop, as shown in 2016 reanalysis of unpublished data. Taubes highlights these as suppressed results that contradicted the hypothesis, with organizers like Ivan Frantz expressing disappointment but not publicizing the harms. Further undermining the hypothesis, Taubes notes the Multiple Risk Factor Intervention Trial (MRFIT, 1982), a $115 million study of 12,866 high-risk men, where intensive counseling to reduce fat and cholesterol alongside smoking cessation and blood pressure control showed no mortality benefit over usual care, suggesting potential lifespan shortening from low-fat interventions. The Lipid Research Clinics Coronary Primary Prevention Trial (1984), costing $140 million, demonstrated modest heart disease reduction via cholestyramine but extrapolated dietary implications without trial evidence, ignoring that saturated fats also raise protective HDL cholesterol. Taubes argues this evidential weakness prompted the 1977 McGovern Senate committee to impose low-fat guidelines amid political pressure, sidelining scientific dissent and fostering a paradigm where high-carbohydrate replacements exacerbated obesity and insulin resistance without addressing root causes.

Advocacy for Carbohydrate-Insulin Model of Obesity

Gary Taubes advocates the carbohydrate-insulin model (CIM) of obesity, which asserts that diets rich in refined and easily digestible carbohydrates—such as sugars, white flour, and starches—trigger pronounced insulin responses that favor fat deposition in , inhibit fat breakdown, partition energy away from lean tissues, and heighten signals, thereby promoting passive overeating and irrespective of total caloric intake. This contrasts with the dominant energy balance model, which treats as a simple mismatch of calories consumed versus expended, a view Taubes deems insufficient for explaining why low-fat, high-carbohydrate diets have coincided with surging rates since the late 1970s. In his 2007 book Good Calories, Bad Calories, Taubes delineates the mechanism: carbohydrates elevate blood glucose, prompting insulin secretion to shuttle calories into fat cells for storage while suppressing (fat release), creating an deficit that drives compensatory hyperphagia without conscious . He supports this with historical evidence, including early-20th-century experiments where rodents and humans fattened rapidly on carbohydrate-heavy diets low in fat, and epidemiological observations like the Pima Indians' shift from leanness on traditional low-carb diets to after adopting and sugars in the . Taubes further argues that insulin's primacy in fat regulation explains clinical trial outcomes, such as meta-analyses from the 2000s showing low-carbohydrate diets yielding 1-2 kg greater short-term than low-fat alternatives under conditions, attributable to reduced insulin and enhanced oxidation rather than mere caloric restriction. In a 2012 New York Times op-ed, he stated: "The obvious mechanism: carbohydrates stimulate secretion of the hormone , which works, among other things, to store in our cells" and suppress hunger-suppressing hormones like , reinforcing the cycle. To empirically test CIM predictions, Taubes co-founded the Nutrition Science Initiative (NuSI) in 2012, funding randomized controlled trials including a 2016-2018 study of 164 adults where low-carbohydrate participants (20-40g carbs/day) lost an average of 2.2 kg more body fat than low-fat counterparts (under eucaloric conditions), with lower insulin levels correlating to greater fat mobilization. He interprets such results as vindicating CIM's emphasis on dietary composition's hormonal effects over willpower or exercise, critiquing institutional nutrition science for prioritizing energy balance due to entrenched paradigms dating to ' mid-century work. Taubes maintains this advocacy in later writings, linking the model's implications to ketogenic or very-low-carbohydrate regimens that minimize insulin excursions, as evidenced by sustained remissions in trials following carb restriction.

Major Publications

Good Calories, Bad Calories and Why We Get Fat

Good Calories, Bad Calories, published on September 25, 2007, by , presents Taubes's extensive investigation into the origins and validity of dietary recommendations promoting low-fat, high-carbohydrate diets. Taubes contends that the prevailing paradigm, which attributes , , and heart disease primarily to dietary and excess calories, lacks robust empirical support and stems from flawed interpretations of mid-20th-century research, such as Ancel Keys's selective use of data in the Seven Countries Study. Instead, he posits a carbohydrate-insulin model, where refined carbohydrates and sugars elevate insulin levels, promoting storage, hunger, and metabolic dysfunction rather than simple caloric surplus driving . Drawing on historical clinical observations, like those from the 19th-century Wilhelm Banting's low-carbohydrate regimen and early 20th-century experiments by researchers such as Frederick Allen on and insulin's role in , Taubes argues that carbohydrates, particularly easily digestible ones, are the causal agents in chronic diseases previously blamed on fats. The book critiques the post-World War II shift in , highlighting how U.S. government and institutional endorsements of low-fat diets—exemplified by the 1977 McGovern Committee report—relied on associative rather than controlled trials demonstrating . Taubes examines evidence from randomized trials, such as the 1960s work of , who linked sugar to heart disease before facing professional marginalization, and contrasts it with the underwhelming results of low-fat interventions like the , where participants on reduced-fat diets showed no significant or cardiovascular benefits after years of adherence. He emphasizes physiological mechanisms: insulin not only facilitates but inhibits fat breakdown (), leading to a feedback loop of fat accumulation independent of total energy intake, supported by observations that obese individuals often consume fewer calories than lean counterparts when normalized for body size. Why We Get Fat: And What to Do About It, released in December 2010 as a more concise and accessible distillation of Good Calories, Bad Calories's arguments, reinforces the carbohydrate-insulin hypothesis while providing practical guidance. Taubes reiterates that arises from hormonal dysregulation—primarily induced by chronic carbohydrate consumption—rather than thermodynamic imbalance, citing evolutionary mismatches where modern refined carbs overwhelm ancestral metabolic adaptations. The book reviews supportive evidence, including population studies showing rising paralleling increased intake since the 1970s and clinical outcomes from low-carbohydrate s, such as those in the 2003 Atkins trials where participants lost more weight and improved lipid profiles compared to low-fat groups. Taubes advocates eliminating refined carbs and s to restore hormonal balance, arguing this approach aligns with first-hand accounts from physicians like Blake Donaldson, who successfully treated with meat-and-fat diets in the early 1900s, and warns against equating all calories equally due to their differential metabolic effects.

The Case Against Sugar

The Case Against Sugar, published on December 27, 2016, by , synthesizes Taubes's critique of refined sugars—primarily and —as primary drivers of metabolic diseases including , , , and cancer. Taubes posits that these sugars function as toxins, uniquely metabolized to promote fat synthesis, , and , effects not replicated by other macronutrients at equivalent caloric intakes. Drawing on historical patterns, he notes that sugar consumption surged from 10 pounds annually in 1800 to over 150 pounds by the late , paralleling rises in and rates from negligible to epidemic levels. Taubes structures his case around biological mechanisms, industry obfuscation, and institutional denial, likening sugar's trajectory to tobacco's delayed recognition as carcinogenic. He emphasizes fructose's hepatic processing, which generates triglycerides and lipogenesis, bypassing normal signals and elevating , as evidenced by studies where sugar-fed animals exhibited , fatty liver, and even when calories were controlled. Human correlational data, such as Pacific Island populations developing upon adopting sugar-rich diets, further support this, Taubes argues, challenging the energy-balance model that treats as mere caloric surplus without regard to hormonal regulation. He critiques the sugar industry's funding of research to shift blame to fats, mirroring tobacco tactics documented in internal memos from the onward. The book also addresses and cigarettes as analogs—substances addictive and disease-causing yet long defended despite early warnings—urging a precautionary approach to restriction. Taubes acknowledges gaps in randomized trials but contends epidemiological consistencies and mechanistic plausibility outweigh them, given science's history of errors like the dietary fat hypothesis. Critics contend he overinterprets animal data and underemphasizes overall energy intake or genetics, yet Taubes counters that such views perpetuate flawed paradigms resistant to paradigm shifts.

Rethinking Diabetes and Recent Works

In Rethinking Diabetes: What Science Reveals About Diet, Insulin, and Successful Treatments, published on January 2, 2024, Gary Taubes investigates the historical trajectory of research and management for both type 1 and type 2 variants, contending that pre-1921 treatments emphasizing restriction—pioneered by figures such as John Rollo in 1797 and —effectively controlled symptoms and extended without insulin, yet were supplanted post-insulin discovery by regimens promoting high-carbohydrate diets alongside pharmacological interventions. Taubes attributes this shift to institutional preferences for drug-centric models over dietary discipline, arguing it exacerbated the condition's progression despite advancements in monitoring and medications. Taubes dedicates the book to endocrinologist Sarah Hallberg, who demonstrated remission via low-carbohydrate nutrition in clinical settings before her death in 2022, and draws on physiological evidence to frame the disease as a disorder driven by chronic rather than obesity alone. He critiques contemporary guidelines from bodies like the , which half of patients fail to meet for blood glucose control, asserting that elevated carbohydrate intake perpetuates and metabolic dysfunction, while low-carbohydrate, higher-fat diets reduce insulin requirements and improve outcomes, as evidenced by historical case series and modern trials like those from Virta Health showing sustained remission in . The work highlights diabetes's transformation from a rare 19th-century affliction—comprising under 1% of populations in studies—to a U.S. affecting 1 in 9 adults, with annual healthcare costs exceeding $400 billion, linking this rise to post-World War II dietary shifts toward refined sugars and starches amid flawed epidemiological assumptions equating all calories equally. Taubes advocates recentering treatment on empirical dietary trials over incremental , warning that current approaches treat symptoms without addressing root causes like carbohydrate-induced fat storage and beta-cell exhaustion. Complementing the book, Taubes adapted excerpts into essays, such as a , 2024, Time piece on treatment paradoxes, reinforcing that insulin's introduction inadvertently normalized by enabling carbohydrate-heavy diets, and he continues discussing these themes in public forums, including a May 2024 presentation at the Public Health Collaboration conference. These efforts underscore his broader critique of science's reliance on observational data over mechanistic and therapeutic experiments, positioning low-carbohydrate approaches as a viable alternative supported by clinical reversals rather than consensus-driven inertia.

Nutrition Science Initiative (NuSI)

Founding and Objectives

The Nutrition Science Initiative (NuSI) was co-founded in February 2012 by and , with the headquartered in , . It was publicly launched on , 2012, as a nonprofit entity aimed at addressing perceived flaws in the prevailing understanding of . Initial funding, totaling over $40 million in commitments, came primarily from philanthropists and John Arnold through their foundation, enabling NuSI to support multimillion-dollar research grants without reliance on government or industry sources. NuSI's core objective was to generate definitive, evidence-based answers to the causes of and related chronic diseases, such as , by funding rigorous, controlled clinical trials that could resolve longstanding scientific debates. The initiative explicitly sought to test and potentially overturn the dominant "energy balance" —which posits primarily as a result of caloric intake exceeding expenditure—against alternative physiological explanations, including the role of carbohydrates in driving insulin secretion and fat storage. By prioritizing hypothesis-driven research over observational , NuSI aimed to produce transformative science capable of reducing the economic and social burdens of , estimated at hundreds of billions of dollars annually in healthcare costs. This approach was framed as a "" for , emphasizing first-principles experimentation to identify causal mechanisms rather than perpetuating what founders viewed as decades of inconclusive, low-quality studies influenced by institutional biases in . NuSI committed to by pre-registering studies, sharing data openly, and focusing on outcomes like body fat regulation independent of willpower or behavioral factors. The ultimate goal was to inform , clinical guidelines, and dietary recommendations with unambiguous evidence, potentially shifting focus from low-fat, calorie-restricted diets to interventions targeting hormonal and metabolic drivers.

Research Outcomes and Challenges

The Nutrition Science Initiative (NuSI) funded four primary research projects between 2012 and 2021 aimed at testing the mechanistic roles of macronutrients, particularly carbohydrates, in and , with a focus on the carbohydrate-insulin model (CIM). These included a short-term metabolic , a rodent experiment on dietary effects, and two larger randomized controlled trials in s examining energy expenditure and maintenance. One key outcome emerged from a NuSI-supported led by Cara Ebbeling and David Ludwig, published in 2018, involving 164 adults with or who first lost 12% of body weight on a standard diet. During a 20-week maintenance phase, participants assigned to a (20% carbs, 20% protein, 60% fat) exhibited total energy expenditure approximately 209 kcal/day higher than those on a (60% carbs, 20% fat, 20% protein), as measured by , with corresponding increases in fat oxidation and resting expenditure. This finding aligned with CIM predictions that reduced carbohydrate intake lowers insulin secretion, thereby increasing energy expenditure and potentially aiding weight maintenance, though actual weight regain differences were modest (low-carb: -0.6 kg vs. low-fat: +1.9 kg). In contrast, a separate NuSI-funded 12-month randomized by Christopher Gardner and colleagues, involving 609 adults, compared healthy low-fat (48% carbs) and healthy low-carbohydrate (30% carbs) diets after initial group counseling. Both groups achieved similar mean (low-fat: -5.3 kg; low-carb: -6.0 kg), with no significant difference, and comparable improvements in cardiovascular risk factors, suggesting that macronutrient composition did not substantially outperform overall dietary quality or in promoting sustained under these conditions. Challenges in NuSI's research efforts included methodological hurdles in designing studies capable of isolating causal effects of macronutrients from caloric intake and behavioral factors, leading to critiques over study duration, participant adherence, and interpretation of null or modest results. For instance, extensive post-hoc analyses and disputes arose in the Ebbeling-Ludwig trial, with some researchers arguing that the energy expenditure differences were overstated due to unaccounted variables like or adaptive , while NuSI provided detailed feedback questioning conclusions that downplayed metabolic advantages of low-carb diets. constraints emerged as major obstacles; initial pledges of up to $40 million from donors like the Laura and John Arnold Foundation supported early work but tapered off amid inconclusive outcomes and shifting priorities, contributing to operational difficulties and the organization's inability to scale to larger, definitive trials. These issues culminated in NuSI's dissolution on , 2021, after expending approximately $20 million, with co-founder Gary Taubes acknowledging that while the initiative generated evidence challenging simplistic caloric-balance models—such as elevated energy expenditure on low-carb regimens—it failed to produce the "unambiguous" paradigm-shifting results envisioned, partly due to entrenched resistance in paradigms and the complexity of long-term trials. Despite this, proponents credit NuSI with catalyzing for similar studies and highlighting insulin's understudied role in .

Ongoing Advocacy and Public Engagement

Debates on Diet Versus Pharmacological Interventions

Taubes has critiqued the prioritization of pharmacological interventions like GLP-1 receptor agonists (e.g., in Ozempic and Wegovy) over dietary changes for treating , arguing that the former often mask symptoms without resolving underlying hormonal dysregulation. In clinical trials, has demonstrated average of 15-17% after 68 weeks, yet Taubes notes high discontinuation rates—often exceeding 50% within a year—due to gastrointestinal side effects, muscle loss, and cost barriers, raising questions about long-term adherence and efficacy. He contrasts this with low-carbohydrate diets, which, per the carbohydrate-insulin model he champions, reduce insulin secretion and promote fat mobilization by addressing carbohydrate-driven , potentially yielding comparable or superior sustained results without daily injections or dependency. Drawing historical parallels, Taubes warns that emphasizing drugs echoes the early 20th-century shift to insulin for , which alleviated but overlooked dietary restriction, contributing to vascular complications and escalating insulin requirements over time. He posits that GLP-1 agonists may indirectly mimic low-carb effects by suppressing appetite and altering gut hormones, but their mechanism—potentially restoring access to "trapped" —underscores diet's primacy, as pharmacological suppression of signals fails to re-educate metabolic responses post-treatment. In his view, rigorous randomized trials of ad libitum low-carb diets, akin to those for drugs, remain underfunded, perpetuating a bias toward profitable interventions despite evidence from smaller studies showing reversal of and without medication. Taubes has voiced these concerns in public forums, including podcasts where he disputes proponents like Peter Attia, emphasizing unknown risks of GLP-1 drugs such as pancreatic inflammation, thyroid tumors in rodents, and fertility impacts, against diets' established safety profile when carbohydrate-restricted. He advocates testing post-drug maintenance via low-carb regimens to prevent regain, citing trial data where weight rebounds rapidly upon discontinuation, with over 60% of lost weight often regained within a year absent lifestyle changes. This debate highlights Taubes's broader contention that obesity's etiology as a hormonal disorder favors causal dietary fixes over symptomatic palliation, urging a reevaluation of public health guidelines that undervalue empirical testing of carbohydrate reduction.

Substack and Media Contributions

In December 2024, Taubes launched his independent newsletter Uncertainty Principles, which focuses on unresolved questions and debates in science, , , and , emphasizing the importance of acknowledging ignorance over dogmatic certainty. The publication serves as a platform for investigative pieces challenging mainstream narratives, informed by Taubes's decades of reporting on nutrition controversies. As of late 2025, it has attracted over 17,000 free subscribers and more than 100 paid subscribers, offering free newsletters alongside premium content such as early access and archives for supporters. Notable posts include "Is There a Boring Truth About ?" on October 5, 2025, which disputes simplistic caloric surplus explanations for the U.S. by highlighting historical inconsistencies and hormonal factors. Another entry, "The BodyBuilder Bias, or Why Lean People Can Be Clueless about ," published October 18, 2025, examines how personal leanness may foster biases against metabolic models of fat storage, referencing empirical challenges to energy balance orthodoxy. Earlier contributions to collaborative platforms, such as guest posts on Teicholz's Unsettled , include "Lessons from the Trial" in August 2023, critiquing the trial's design flaws and limited applicability to prevention despite hype. Taubes has sustained media engagement through interviews and podcasts promoting low-carbohydrate paradigms and critiquing epidemiological weaknesses in . In an October 30, 2024, episode of Tara Henley's Lean Out podcast, he discussed hormonal drivers of fat accumulation and the shortcomings of caloric restriction, tying these to his book Rethinking Diabetes. A September 6, 2024, appearance on the Mind and Matter podcast addressed systemic issues in , including reliance on observational data prone to and the influence of social factors over rigorous causation. These outlets allow Taubes to counter prevailing views, often citing randomized favoring restriction for metabolic .

Controversies and Scientific Debates

Criticisms from Caloric Balance Proponents

Caloric balance proponents, including researcher Kevin Hall, contend that Taubes's carbohydrate-insulin model (CIM) erroneously subordinates the first law of —requiring energy intake to exceed expenditure for fat storage—to secondary hormonal mechanisms, thereby inverting causality in . They assert that from controlled feeding trials demonstrates weight gain and loss are primarily driven by net energy imbalance, with carbohydrate restriction offering no unique advantage when calories are equated. For instance, Hall's 2016 published in Cell Metabolism compared ad libitum low-carbohydrate and isocaloric high-carbohydrate diets in 17 adults over four weeks, finding similar reductions in body fat mass (approximately 1 kg in both groups), which proponents interpret as refuting CIM predictions of superior fat oxidation and reduced on low-carb regimens.30243-0) Critics further argue that Taubes misrepresents historical and contemporary data by dismissing calorie-restrictive interventions as ineffective or unsustainable, despite meta-analyses showing short-term efficacy in producing across macronutrient compositions. In a 2017 review in the American Journal of Clinical Nutrition, Hall and co-authors evaluated CIM against the energy balance model (EBM), highlighting that overfeeding studies—such as those inducing surplus s via fats or carbs—consistently increase body fat regardless of insulin levels, underscoring energy surplus as the causal driver rather than carbohydrate-induced . Proponents like Stephan Guyenet echo this, claiming Taubes cherry-picks evidence while ignoring how environmental factors (e.g., ultra-processed foods) elevate intake, leading to imbalance, and that his model's failure in NuSI-funded trials (e.g., limited spontaneous calorie reduction on low-carb arms) undermines its validity.00069-7/fulltext) Additional rebukes focus on Taubes's alleged selective , where he portrays the post-World War II adoption of EBM as a error influenced by flawed assumptions, yet caloric balance advocates point to longstanding physiological data, including Keys's semi-starvation experiments (1944–1945), where energy deficit induced fat loss irrespective of diet composition, as foundational support for EBM's primacy. They maintain that while insulin influences nutrient partitioning, it does not override energy conservation laws, and Taubes's advocacy risks misleading public policy by de-emphasizing portion control and in favor of unproven carb vilification. These critiques, often from federally funded researchers, reflect a broader institutional in nutrition science favoring EBM, though skeptics note potential conflicts from long-standing low-fat paradigms.

Responses and Empirical Evidence Supporting Taubes's Views

Proponents of the carbohydrate-insulin model (CIM), including Taubes, respond to caloric balance advocates by asserting that the energy balance equation is an uninformative describing weight change after it occurs, rather than explaining the underlying physiological drivers of fat accumulation and appetite dysregulation. They argue that elevated insulin from consumption actively promotes storage, suppresses fat oxidation, and signals the to increase and reduce energy expenditure, independent of total caloric intake. This hormonal mechanism, they contend, better accounts for why populations consuming high-glycemic-load diets exhibit rising rates despite stable or declining overall energy intake in some historical contexts. Empirical support includes randomized controlled trials (RCTs) demonstrating superior short-term on low-carbohydrate diets compared to low-fat alternatives. A 2020 of 26 RCTs involving over 1,500 participants found low-carbohydrate diets yielded greater reductions in body weight (mean difference -1.77 kg at 6-12 months) and improved cholesterol and triglycerides, effects attributed to reduced insulin secretion and enhanced fat mobilization. Another 2022 of seven long-term studies reported low-carbohydrate diets associated with 2.72 kg greater at 3-4 months and sustained cardiovascular improvements, such as lower diastolic , over 12 months. In management, low-carbohydrate interventions show robust glycemic benefits. A 2023 meta-analysis of RCTs indicated low-carbohydrate diets reduced HbA1c by 0.47% more than higher-carbohydrate controls at 6 months, alongside greater fat mass loss, without adverse effects on in most cases. Early 20th-century clinical observations, replicated in modern trials, document diabetes reversal through carbohydrate restriction, with fasting glucose dropping significantly (e.g., from 200+ mg/dL to near-normal) and insulin requirements eliminated in non-insulin-dependent patients within weeks. A 2003 RCT of 63 obese participants found low-carbohydrate diets produced 4% greater absolute than conventional low-fat diets over six months, with participants reporting less despite ad libitum eating. Isocaloric feeding studies further bolster the CIM by isolating macronutrient effects. In a crossover trial by Ludwig et al., overweight adults on high-glycemic carbohydrate loads expended 209 more calories per day via increased expenditure and reduced sedentary time compared to low-glycemic or high-fat diets, supporting carbohydrate-driven metabolic inefficiency. These findings counter caloric balance primacy by evidencing substrate-specific influences on partitioning and expenditure, though critics note long-term adherence challenges limit generalizability. Overall, while not universally superior beyond in all trials, the pattern of metabolic improvements—lower insulin, better dyslipidemia, and visceral fat reduction—aligns with Taubes's emphasis on s as primary obesogenic agents.

Awards and Recognition

[Awards and Recognition - no content]

References

  1. [1]
    Biography - Gary Taubes
    Gary Taubes is an investigative science and health journalist and co-founder of the non-profit Nutrition Science Initiative (NuSI.org).
  2. [2]
    Taubes, Gary 1956– | Encyclopedia.com
    Taubes, Gary 1956–. PERSONAL: Born April 30, 1956; married; children: one son. Education: Graduated from Harvard University.
  3. [3]
    Books - Gary Taubes
    He is the author of Rethinking Diabetes (2024), The Case Against Sugar (2016), Why We Get Fat and What to Do About ... Read More » ...Missing: notable | Show results with:notable
  4. [4]
    Gary Taubes - Swiss Re
    Investigative science and health journalist. Gary Taubes began writing and reporting on science and medicine for Discover magazine in 1982.
  5. [5]
    Gary Taubes | Robert Wood Johnson Foundation
    He began writing and reporting on science and medicine for Discover magazine in 1982. He has been a contributing correspondent for the journal Science since ...Missing: biography | Show results with:biography
  6. [6]
    Gary Taubes - Penguin Random House Speakers Bureau
    Gary Taubes is an award-winning investigative science and health journalist, nutrition expert, and co-founder of the Nutrition Science Initiative.Missing: biography | Show results with:biography
  7. [7]
    The Dissolution of the Nutrition Science Initiative - Gary Taubes
    Dec 31, 2021 · Gary Taubes is an investigative science and health journalist and co-founder of the non-profit Nutrition Science Initiative (NuSI.org). He is ...Missing: controversies | Show results with:controversies
  8. [8]
    Thin Body of Evidence: Why I Have Doubts about Gary Taubes's ...
    May 16, 2011 · In a 2002 cover story for The New York Times Magazine, Gary questioned the truism that people are getting fatter because they eat too much— ...
  9. [9]
    Gary Taubes: 'Obesity isn't a calorie problem, it's a hormone problem'
    Jan 17, 2021 · Over the past 20 years, Taubes has suggested that fat has been unfairly demonised, and instead our excessive carbohydrate and sugar consumption ...
  10. [10]
    An Interview with . . . Gary Taubes, Investigative Journalist and Author
    Dec 18, 2019 · GARY TAUBES: I have a master's in science and engineering from Stanford. ... After journalism school, the best jobs I could get were in science ...Missing: biography | Show results with:biography
  11. [11]
    STEM-Talk 37 Gary Taubes discusses low-carb diets and sheds ...
    May 9, 2017 · He graduated from Harvard College in 1977 with an S.B. degree in applied physics and went on to earn an M.S. degree in aeronautical engineering ...
  12. [12]
    #167 - Gary Taubes: Bad science and challenging the conventional ...
    Jun 28, 2021 · Gary's background in science and journalism, and developing a healthy skepticism for science [2:20] · majored in applied physics at Harvard ...
  13. [13]
    Gary Taubes (author of Why We Get Fat) - SoBrief
    His background in physics and journalism has influenced his approach to investigating and reporting on complex scientific issues, making him a prominent figure ...
  14. [14]
    Interview With Gary Taubes (part 1) - Science 2.0
    Jan 3, 2008 · GARY TAUBES: Well, I've spent over 20 years now writing about controversial science. In the mid-1980s, I lived at CERN for ten months, the big ...Missing: early career
  15. [15]
    Nobel Dreams: Power, Deceit, and the Ultimate Experiment
    Title, Nobel Dreams: Power, Deceit, and the Ultimate Experiment ; Author, Gary Taubes ; Publisher, Random House, 1986 ; Original from, the University of Michigan.
  16. [16]
    Nobel Dreams: Power, Deceit, and the Ultimate Experiment
    Rating 4.0 (65) Nobel Dreams is a fascinating work of science journalism written by a former physicist that vividly captures experimental particle physics right at the turning ...
  17. [17]
    1990 Story by Gary Taubes in Science - New Energy Times
    Jun 15, 1990 · WHEN TRITIUM FIRST APPEARED in John Bockris's "cold fusion" experiments in late April 1989, the effect was anything but subtle. Overnight the ...
  18. [18]
    Bad Science: The Short Life and Weird Times of Cold Fusion
    Gary Taubes is an investigative science and health journalist and co-founder of the non-profit Nutrition Science Initiative (NuSI.org). He is the author of Why ...
  19. [19]
    Bad Science. The Short Life and Weird Times of Cold Fusion. Gary ...
    Cold Fusion Revisited: Bad Science. The Short Life and Weird Times of Cold Fusion. Gary Taubes. Random House, New York, 1993. xxii, 503 pp. $24.50. · Formats ...Missing: reporting | Show results with:reporting
  20. [20]
    A Cold Shoulder to Science : BAD SCIENCE: The Short Life and ...
    Aug 22, 1993 · For a hoax is what cold fusion was. Taubes documents that beyond reasonable doubt: the scandalously incomplete experiments, the tactical ...
  21. [21]
    COLD-FUSION FIASCO NOT ONE OF SCIENCE'S FINER MOMENTS
    Jul 25, 1993 · Author Gary Taubes, who has training as both a scientist and a journalist, has written a marvelous chronicle of the cold-fusion affair. Aided by ...
  22. [22]
    [PDF] The Soft Science of Dietary Fat - Gary Taubes
    "Report on Nutrition and Health," declaring fat the single most unwholesome compo- nent of the American diet. All of this was apparently based on sound science.
  23. [23]
    Interview - Gary Taubes | Diet Wars | FRONTLINE - PBS
    Apr 8, 2004 · In this interview, Taubes explains his motivation for writing his piece, the science behind the low-carbohydrate diet, and the contention he ...Missing: influences | Show results with:influences
  24. [24]
    Vegetable oils, (Francis) Bacon, Bing Crosby, and the ... - Gary Taubes
    Jun 17, 2017 · One of them, for instance, is the Oslo Diet-Heart Study. This trial reported a significant reduction in CVD events, in line with the beliefs ...
  25. [25]
    What if It's All Been a Big Fat Lie? - The New York Times
    Jul 7, 2002 · Gary Taubes article says that American medical establishment may have caused nation's obesity epidemic by recommending low-fat, ...
  26. [26]
    The Carbohydrate-Insulin Model of Obesity: Beyond 'Calories In ...
    Thus, the Carbohydrate-Insulin Model of obesity (CIM) proposes that a high-carbohydrate diet – including large amounts of refined starchy foods and sugar, as ...
  27. [27]
    Good Calories, Bad Calories (2007) - Gary Taubes
    In Good Calories, Bad Calories, Taubes tries to bury the idea that a low-fat diet promotes weight loss and better health.
  28. [28]
    Opinion | What Really Makes Us Fat - The New York Times
    Jun 30, 2012 · The obvious mechanism: carbohydrates stimulate secretion of the hormone insulin, which works, among other things, to store fat in our fat cells.Missing: hypothesis | Show results with:hypothesis
  29. [29]
    Good Calories, Bad Calories: Challenging the Conventional ...
    30-day returnsIn Good Calories, Bad Calories, Taubes tries to bury the idea that a low-fat diet promotes weight loss and better health. Obesity is caused, he argues, not ...
  30. [30]
    Good Calories, Bad Calories | Summary, Quotes, FAQ, Audio - SoBrief
    Rating 4.6 (82) Jan 23, 2025 · Good Calories, Bad Calories challenges conventional wisdom on diet and health, arguing that refined carbohydrates, not fats, are the primary ...
  31. [31]
    Good Calories Bad Calories: Fats, Carbs, and the Controversial ...
    Jan 31, 2020 · ... Bad Calories: Fats, Carbs, and the Controversial Science of Diet and Health ... Good Calories, Bad Calories and Taubes' second book Why We Get Fat ...
  32. [32]
    Good Calories, Bad Calories - Gary Taubes - Books - Review
    Oct 7, 2007 · For example, Taubes argues at length that people get fat because carbohydrates in their diet drive up the insulin level in the blood, which in ...
  33. [33]
    [PDF] The Soft Science of Dietary Fat Author(s) - Gary Taubes
    Fat is also the primary component of cell membranes. Changing the proportion of saturated to un- saturated fats in the diet changes the fat composition in these ...
  34. [34]
    [PDF] Good Calories, Bad Calories by Gary Taubes; New York: AA Knopf
    Good Calories, Bad Calories is a scholarly book that musters the evidence for the case against the high-fat hypothesis for heart disease, cancer and obesity and ...
  35. [35]
    Why We Get Fat: And What to Do About It: Taubes, Gary - Amazon.com
    Persuasive, straightforward, and practical, Why We Get Fat is an essential guide to nutrition and weight management. Complete with an easy-to-follow diet.
  36. [36]
    The Author Speaks: Gary Taubes Interview, 'Why We Get Fat ... - AARP
    Jan 20, 2011 · Taubes' book is a primer on how the hormones and enzymes that control the body's fat storage really work, how what we've been eating has mucked up our systems.
  37. [37]
    Gary Taubes on Calories vs. Carbs, The Case Against Sugar, and ...
    Sep 11, 2017 · Gary argues for a “hormonal hypothesis” of obesity, based on the idea that excessive intake of highly-refined carbohydrates (e.g., sugar, white ...
  38. [38]
    The Case Against Sugar by Gary Taubes - Penguin Random House
    In stock Rating 4.5 18 Product Details. ISBN9780307946645. Published onDec 12, 2017. Published byVintage. Pages384. Dimensions5-3/16 x 8. Author. Gary Taubes. GARY TAUBES is the ...
  39. [39]
    What Not to Eat: 'The Case Against Sugar' - The New York Times
    Jan 2, 2017 · And what causes insulin resistance and metabolic syndrome? Taubes blames sugar, the “dietary trigger” hiding in plain sight for over half a ...
  40. [40]
    Gary Taubes's New Book Puts Sugar On Trial | Psychology Today
    Jan 25, 2017 · In The Case Against Sugar, science writer Gary Taubes shows how Sugar fronts distorted science and politicized nutrition politics to sell ...
  41. [41]
    Review: 'The Case Against Sugar,' by Gary Taubes - The Atlantic
    Feb 15, 2017 · “I actually think the evidence is ambiguous,” he said in a recent interview on sugar. “I mean if it was a criminal case, you would have ...
  42. [42]
    Bad sugar or bad journalism? An expert review of “The Case ...
    Jan 26, 2017 · The Case Against Sugar is a journey through sugar history and science that argues the point that sugar is the principal cause of obesity, diabetes, coronary ...Missing: summary | Show results with:summary
  43. [43]
    Gary Taubes on the Case Against Sugar - Econlib
    Feb 6, 2017 · Taubes concedes the evidence is not iron-clad or definitive and reflects along the way on the intellectual and personal challenges of holding a ...
  44. [44]
    The Case against Sugar Isn't So Easily Dismissed - Cato Unbound
    Jan 30, 2017 · Gary Taubes replies to his critics on the link between sugar and obesity, and on the link between government advice and overconsumption.
  45. [45]
    Rethinking Diabetes by Gary Taubes - Penguin Random House
    In stock Free deliveryAn eye-opening investigation into the history of diabetes research and treatment by the award-winning journalist and best-selling author of Why We Get Fat.
  46. [46]
    Summary of Gary Taubes's Rethinking Diabetes — Kalamazoo ...
    The book traces the history of diabetes management, from early low-carbohydrate, high-fat diets to the introduction of insulin in 1921, which shifted dietary ...
  47. [47]
    Unlocking the truth about diabetes: 'The science has been pretty awful'
    Jan 14, 2024 · For Taubes, dietary fat wasn't a problem at all. Instead, the real danger was carbohydrate, he asserted, sparking a backlash, and fuelling the ...
  48. [48]
  49. [49]
    Rethinking Diabetes: What Science Reveals About Diet, Insulin, and ...
    Feb 6, 2025 · Taubes dedicates the book to the late Dr Sarah Hallberg, who championed low carbohydrate nutrition to manage and even reverse type 2 diabetes.
  50. [50]
    Rethinking Diabetes. - Gary Taubes
    Jan 2, 2024 · My new book, Rethinking Diabetes, addresses all of this and it's out today. I have a Q&A on the Unsettled Science substack addressing these ...<|separator|>
  51. [51]
    Rethinking Diabetes: What Science Reveals About Diet, Insulin, and ...
    Jun 28, 2024 · ... Taubes G. (2001). Nutrition. The soft science of dietary fat. Science (New York, N.Y.), 291(5513), 2536–2545. https://doi.org/10.1126 ...
  52. [52]
    Rethinking Diabetes: What Science Reveals About Diet, Insulin, and ...
    The result of Taubes's work is a reimagining of diabetes care that argues for a recentering of diet—particularly, fewer carbohydrates and more fat—over a ...
  53. [53]
    The Paradox of How We Treat Diabetes - Time Magazine
    Jan 3, 2024 · Adapted from Gary Taubes' new book Rethinking Diabetes: What Science Reveals About Diet, Insulin and Successful Treatments. More Must-Reads ...
  54. [54]
  55. [55]
    Gary Taubes // Rethinking Diabetes #PHC2024 - YouTube
    Nov 6, 2024 · On Saturday 18th and Sunday 19th May 2024, Public Health Collaboration hosted our 8th annual conference in London at Fairfield Halls.
  56. [56]
    Book Review: Rethinking Diabetes, by Gary Taubes - LinkedIn
    Sep 29, 2024 · Summary. This is a detailed investigation into the history of diabetes (type 1 and type 2) research and treatment. Before the discovery of ...
  57. [57]
    [PDF] Introduction to NuSI | Open Philanthropy
    NuSI was co-founded in February 2012 by Gary Taubes and. Peter Attia, M.D. and is located in San Diego, CA. Funding for NuSI comes from the Laura and John.
  58. [58]
    The Launch of The Nutrition Science Initiative - Gary Taubes
    Sep 12, 2012 · NuSI was founded to address this issue and by doing so, we hope, reduce the social and economic burden of obesity and its related diseases.Missing: objectives | Show results with:objectives
  59. [59]
    The Struggles of a $40 Million Nutrition Science Crusade | WIRED
    Jun 18, 2018 · Taubes had issues with both the researchers' conclusions and many of the study's designs, which fed participants a “standard American diet” for ...Missing: controversies | Show results with:controversies<|control11|><|separator|>
  60. [60]
    Billionaires Fund A 'Manhattan Project' For Nutrition And Obesity
    Sep 20, 2012 · Billionaires John and Laura Arnold are betting that the country's top nutrition researchers can get to the bottom of the obesity epidemic.Missing: objectives | Show results with:objectives
  61. [61]
    A Manhattan Project To End The Obesity Epidemic - Forbes
    Sep 12, 2012 · The Nutrition Science Initiative (NuSI) is dedicated to dramatically reducing the economic and social burden of obesity and obesity-related ...
  62. [62]
    The Manhattan Project to End Fad Diets - The Blog of Author Tim ...
    Sep 12, 2012 · Born from a shared vision of its co-founders, Peter Attia, M.D. and Gary Taubes, this non-profit will fund research that applies first-of-its- ...
  63. [63]
    Innovative Collaboration Addresses the Science of Nutrition
    Sep 13, 2013 · NuSI is a nonprofit organization dedicated to reducing the economic and social burden of obesity and obesity-related chronic disease by ...Missing: mission | Show results with:mission
  64. [64]
    Nutrition Science Initiative: Are All Calories Created Equal? - Case
    In 2012, Gary Taubes lunched the Nutrition Science Initiative (NuSI), a not-for-profit organization aiming to question the mainstream scientific paradigm ...
  65. [65]
    Effects of a low carbohydrate diet on energy expenditure during ...
    Nov 14, 2018 · Consistent with the carbohydrate-insulin model, lowering dietary carbohydrate increased energy expenditure during weight loss maintenance.
  66. [66]
    Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight ...
    Feb 20, 2018 · In this 12-month weight loss diet study, there was no significant difference in weight change between a healthy low-fat diet vs a healthy low-carbohydrate diet.<|separator|>
  67. [67]
    Diet or Drugs? - by Gary Taubes - Uncertainty Principles
    Feb 16, 2025 · In these trials, the average weight loss for patients on semaglutide (the active component of Wegovy and Ozempic) was 15%-17% after 68 weeks. ...
  68. [68]
  69. [69]
    What Happens When You've Been on Ozempic for 20 Years?
    Apr 15, 2024 · The long-term effects of GLP-1 drugs are unknown. By Gary Taubes. An illustration of GLP-1 drug-injection pens arranged in a circle ...
  70. [70]
    Diet or Drugs 3? First Wegovy, Then What? - by Gary Taubes
    Apr 13, 2025 · ... Semaglutide Treatment Effect in People with Obesity.” Semaglutide is the active ingredient in Wegovy and Ozempic. It's produced by Novo ...
  71. [71]
    39: Gary Taubes: Dangers of Ozempic & Refuting Peter Attia
    May 6, 2024 · Gary Taubes and I discuss the dangers of ozempic and also why he disagrees with Peter Attia. Gary Taubes is an investigative science and health journalist.Missing: semaglutide | Show results with:semaglutide
  72. [72]
    Gary Taubes: Unintended Consequences of Weight Loss “Wonder ...
    Apr 26, 2024 · Prioritizing drugs over lifestyle with insulin therapy, however, led to unexpected long term complications in patients, including damage to large and small ...Missing: semaglutide | Show results with:semaglutide
  73. [73]
    Introducing My New Substack: Uncertainty Principles
    Dec 1, 2024 · Now, I'm excited to announce that I've started my own newsletter called Uncertainty Principles. It may seem like an unusual title for a writer ...
  74. [74]
    About - Uncertainty Principles
    I'm Gary Taubes, an investigative science and health journalist. I'm the author of five books about the very controversial science of nutrition, obesity and ...
  75. [75]
    Uncertainty Principles Substack by Gary Taubes - Sidestack.io
    Visit Substack. Substack details. Author. Gary Taubes. First Posted. December 2024. Free Subscribers. 17K+. Paid Subscribers. 100+. Country. US. Language ...
  76. [76]
    Is There a Boring Truth About Obesity? - Uncertainty Principles
    Oct 5, 2025 · So when he recently wrote a Substack post, “The Boring Truth About Why Americans Got Fat,” and that boring truth, he said, was that we ate too ...
  77. [77]
  78. [78]
    Lessons from the MIND Diet Trial - by Gary Taubes
    Aug 5, 2023 · My first two books were on high energy physicists (Nobel Dreams, 1987) and then chemists and physicists (Bad Science, 1993) who discovered ...
  79. [79]
    Gary Taubes on Why We Get Fat - Lean Out with Tara Henley
    Oct 30, 2024 · Gary Taubes is an award-winning investigative science and health journalist. His latest book is Rethinking Diabetes: What Science Reveals About ...<|separator|>
  80. [80]
    Bad Science, Nutrition Epidemiology, History of Obesity Research ...
    Sep 6, 2024 · About the guest: Gary Taubes is a researcher, science historian, and science journalist. He has written several books, including “Rethinking ...
  81. [81]
    Does energy imbalance (calories in > out) cause obesity?
    Feb 1, 2021 · Gary Taubes argues that energy imbalance (calories in > out) does not cause obesity; rather, energy imbalance is a result of the fattening process.Missing: criticism | Show results with:criticism
  82. [82]
    A new framework for understanding obesity
    Sep 13, 2021 · The authors propose a carbohydrate-insulin model (CIM) for understanding obesity. According to the CIM, obesity is the result of a dysregulated hormonal and ...
  83. [83]
    The carbohydrate-insulin model: a physiological perspective on the ...
    Sep 13, 2021 · The cardiometabolic benefits, including weight loss, of GLP-1 agonism are widely recognized. Recently, the adverse effects of GIP, the incretin ...
  84. [84]
    The Effect of Low-Fat and Low-Carbohydrate Diets on Weight Loss ...
    Dec 9, 2020 · This meta-analysis suggests that low-carbohydrate diets are effective at improving weight loss, HDL and TG lipid profiles.
  85. [85]
    Effectiveness of low‐carbohydrate diets for long‐term weight loss in ...
    LC diets are associated with greater short‐term weight loss than non‐carbohydrate–restricted diets and a longer term favourable effect on cardiovascular risk ...
  86. [86]
    The effects of low-carbohydrate diet on glucose and lipid ... - Frontiers
    Conclusion: Low-carbohydrate diets may enhance glycemic control and lipid profiles in overweight or obese T2DM patients, warranting consideration in T2DM ...Introduction · Methods · Results · Discussion
  87. [87]
    The case for low carbohydrate diets in diabetes management - PMC
    In a recent study [43] on obese diabetic subjects, a LoCHO diet (20% carbohydrates) was associated with a significant reduction in body weight, BMI, fasting ...
  88. [88]
    A Randomized Trial of a Low-Carbohydrate Diet for Obesity
    The low-carbohydrate diet produced a greater weight loss (absolute difference, approximately 4 percent) than did the conventional diet for the first six months.
  89. [89]
    The Effect of Low-Fat and Low-Carbohydrate Diets on Weight Loss ...
    In conclusion, our meta-analysis found higher levels of weight loss for up to 1 year in participants on a low-carbohydrate diet compared to those on a low-fat ...